Continued investigation into the influence of loaded dose on the performance of dry powder inhalers: Surface smoothing effects

Drug Development and Industrial Pharmacy

Volumn 32, Issue 10, 2006, Pages 1135-1138

  El Sabawi, Dina ^a   Edge, Stephen ^a   Price, Robert ^a   Young, Paul M ^b  

^a UNIVERSITY OF BATH   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Active sites; Dry powder inhaler; Lactose; Smoothing

Indexed keywords

LACTOSE; SALBUTAMOL SULFATE;

AEROSOL; ARTICLE; DISSOLUTION; DRUG ACCUMULATION; DRUG FORMULATION; DRUG RESEARCH; DRY POWDER; MASS MEDIUM; POWDER INHALER; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY;

ADMINISTRATION, INHALATION; AEROSOLS; ALBUTEROL; BINDING SITES; BRONCHODILATOR AGENTS; DRUG CARRIERS; LACTOSE; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POWDERS; SURFACE PROPERTIES;

EID: 33750847407     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600712920     Document Type: Article

References (11)

1. Chew, N. Y. K., Tang, P., Chan, H. K., & Raper, J. A. (2005). How much particle surface corrugation is sufficient to improve aerosol performance of powders? Pharmaceutical Research, 22, 148-152.
2. El-Sabawi, D., Price, R., Edge, S., & Young, P. M. (2006). Novel temperature controlled surface dissolution of excipient particles for carrier based dry powder inhaler formulations. Drug Development and Industrial Pharmacy, 32, 243-251.
3. Hersey, J. A. (1975). Ordered mixing-a new concept in powder mixing practice. Powder Technology, 11, 41-44.
4. Kawashima, Y., Serigano, T., Hino, T., Yamamoto, H., & Takeuchi, H. (1998). Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate. International Journal of Pharmaceutics, 172, 179-188.
5. Larhrib, H., Zeng, X. M., Martin, G. P., Marriott, C., & Pritchard, J. (1999). The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate. International Journal of Pharmaceutics, 191, 1-14.
6. Staniforth, J. N. (1995). Performance-modifying influences in dry powder inhalation systems. Aerosol Science and Technology, 22, 346-353.
7. Timsina, M. P., Martin, G. P., Marriott, C., Ganderton, D., & Yianneskis, M. (1994). Drug delivery to the respiratory tract using dry powder inhalers. International Journal of Pharmaceutics, 101, 1-13.
8. Young, P. M., Edge, S., Traini, D., Jones, M. D., Price, R., El-Sabawi, D., Urry, C., & Smith, C. (2005). The influence of dose on the performance of dry powder inhalation systems. International Journal of Pharmaceutics, 296, 26-33.
9. Young, P. M., & Price, R. (2004). The influence of humidity on the aerosolisation of micronised and SEDS produced salbutamol sulphate. European Journal of Pharmaceutical Sciences, 22, 235-240.
10. Zeng, X. M., Martin, G. P., Marriott, C., & Pritchard, J. (2000a). The effects of carrier size and morphology on the dispersion of salbutamol sulphate after aerosolization at different flow rates. Journal of Pharmacy and Pharmacology, 52, 1211-1221.
11. Zeng, X. M., Martin, G. P., Marriott, C., & Pritchard, J. (2000b). The influence of carrier morphology on drug delivery by dry powder inhalers. International Journal of Pharmaceutics, 200, 93-106.